Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma
Shotaro Nakajima(Fukushima Medical University), Koji Kono(Fukushima Medical University), Shinji Ohki(Fukushima Medical University), Tomoyuki Momma, Eisei Endo(Fukushima Medical University), Hirokazu Okayama(Ehime University), Akinao Kaneta(Fukushima Medical University), Hiromasa Ohira(Fukushima Medical University), Aung Kyi Thar Min(Fukushima Medical University), Naoto Yamauchi(Fukushima Medical University), Leo Yamada(Fukushima Medical University), Yasuyuki Kanke(Fukushima Medical University), Suguru Hayase(Fukushima Medical University), Prajwal Neupane(Fukushima Medical University), Hiroyuki Hanayama, Koji Kase(Fukushima Medical University), Yohei Watanabe, Motonobu Saito(Fukushima Medical University), Takuro Matsumoto(Fukushima Medical University), Hiroshi Nakano(Fukushima Medical University), Kosaku Mimura(National Blood Transfusion Service), Katsuharu Saito, Zenichiro Saze
Cited by 43
Related Papers
<scp>PD</scp>‐L1 expression is mainly regulated by interferon gamma associated with <scp>JAK</scp>‐<scp>STAT</scp> pathway in gastric cancer
|Cancer Science|2017|320
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
|PubMed|1996|166
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|143
Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial
|International Journal of Molecular Medicine|2003|136